Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery
Status
Conditions
Treatments
Details and patient eligibility
About
This study evaluates the clinical efficacy and cost effectiveness of Prevena Incision Management System versus Dermabond in preventing groin wound infections in patients who undergo vascular surgery requiring a groin wound. Half of the patients will receive Dermabond and the other half will receive the Prevena Incision Management System for their groin wounds.
Full description
Dermabond and the Prevena Incision Management System are both FDA approved wound care products. Prevena is a negative pressure system which holds the wound together and removes exudate and debris from the site to prevent infection. Dermabond is a surgical glue which holds the wound together to prevents infection. Prevena is more expensive to apply. However, the hypothesis is that the Prevena System will decrease infection rates and therefore, decrease the ultimate cost of the health care needed after surgery.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- In need of elective vascular procedure requiring ≥8 cm groin incision.
- Able to provide consent
- Able to care for wound or have support person to complete wound care
- Willing to comply with follow-up
Exclusion criteria
None
Trial design
Primary purpose
Allocation
Interventional model
Masking
105 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal